Moneycontrol PRO

Buy Abbott India target of Rs 16880: ICICI Direct

  ICICI Direct is bullish on Abbott India has recommended buy rating on the stock with a target price of Rs 16880 in its research report dated February 10, 2020.

February 13, 2020 / 12:50 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

ICICI Direct's research report on Abbott India


The 9MFY20 revenues grew 13.3% YoY to Rs 3132 crore, mainly due to strong growth in key therapies & power brands. EBITDA margins improved 365 bps YoY to 19.7% mainly due to better operational leverage and impact of Ind-As 116. EBITDA grew 39% YoY to Rs 618 crore. Net profit grew 46% YoY to Rs 482 crore. Delta vis-à-vis EBITDA was mainly due to lower tax rate.


Outlook


We expect revenues, EBITDA and PAT to grow at ~13%, 25% and 30% CAGR, respectively, in FY19-22E. We maintain BUY and arrive at a target price of Rs 16880 based on 36x FY22 EPS of Rs 469.


For all recommendations report, click here


Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: Feb 11, 2020 03:21 pm

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark